Press Releases

HAVN Life Enters Supply Agreement with MPB Group Inc.

This new partnership will see the distribution of the Company’s standardized, naturally derived, psilocybin containing mushrooms for therapeutic use at Healing Escapes Foundation retreats in Jamaica Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “HAVN Life”) a biotechnology company pursuing standardized extraction of psychoactive compounds and the …

HAVN Life Enters Supply Agreement with MPB Group Inc. Read More »

HAVN Life To Be Featured On Viewpoint with Dennis Quaid

The Company’s segment will be aired on public television networks across the U.S. starting in July, with interviews featuring CEO Tim Moore and the team leading HAVN Life’s Research and Development Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “HAVN Life”) a biotechnology company pursuing standardized extraction …

HAVN Life To Be Featured On Viewpoint with Dennis Quaid Read More »

HAVN Life Announces Changes to the Board of Directors

Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “HAVN Life”) announces the departure of Messrs. Victor Neufeld and Dennis Staudt, respectively, as Directors of the Company (“Board”), effective immediately. The Company expresses its appreciation for Mr. Neufeld and Mr. Staudt’s services to the Company and wishes them …

HAVN Life Announces Changes to the Board of Directors Read More »

HAVN Life to Present at Upcoming LD Micro Invitational XI

CEO Tim Moore will share recent partnership and distribution news and a roadmap for the Company’s plans for the next quarter Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “HAVN Life”), a biotechnology company pursuing standardized extraction of psychedelic compounds for the creation of APIs that support …

HAVN Life to Present at Upcoming LD Micro Invitational XI Read More »

HAVN Life Signs Supply Agreement with Licenced Jamaican Cannabis Producer, Green Stripe Naturals Ltd.

This new partnership will see the distribution of The Company’s standardized, naturally derived, psilocybin containing mushrooms to local Jamaican dispensaries for legal sale Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “HAVN Life”) a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural …

HAVN Life Signs Supply Agreement with Licenced Jamaican Cannabis Producer, Green Stripe Naturals Ltd. Read More »

HAVN Life Announces Strategic Partnership with Non-Profit Coalition, TheraPsil

Through the Partnership, the Company will seek Health Canada approval to supply naturally-derived psilocybin for legal and therapeutic use via the Special Access Program Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “HAVN Life”), a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of …

HAVN Life Announces Strategic Partnership with Non-Profit Coalition, TheraPsil Read More »

HAVN Life Secures Supply Agreement with Atman Retreats

This new partnership will see the distribution of the Company’s standardized, naturally derived, psilocybin containing mushrooms for therapeutic use at Atman retreats in Jamaica Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “HAVN Life”) a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of …

HAVN Life Secures Supply Agreement with Atman Retreats Read More »

HAVN Life Ships First White Label Order to Distribution Partner Woke Pharmaceuticals in Australia

The successful shipment of white label natural health products will expand the Company’s global retail footprint Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “HAVN Life”) a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural health products, is pleased to announce it …

HAVN Life Ships First White Label Order to Distribution Partner Woke Pharmaceuticals in Australia Read More »

HAVN Life Launches the Brain Evolve Series

The four formulations, helping to reduce inflammation, promote restorative sleep and support cognitive function are now available on yourhavnlife.com Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “HAVN Life”), a biotechnology company developing natural health products and innovative therapies to support brain health and cognitive function, is …

HAVN Life Launches the Brain Evolve Series Read More »

HAVN Life Expands Supply Agreement with Mycotopia Therapies Inc.

The expanded partnership to include the distribution of functional mushrooms, HAVN Life natural health products and white label products, in addition to its naturally-derived psilocybin compounds Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “HAVN Life”) a biotechnology company pursuing standardized extraction of psychoactive compounds and the …

HAVN Life Expands Supply Agreement with Mycotopia Therapies Inc. Read More »

Scroll to Top